Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation

NCT: NCT07220525 · RECRUITING

NCT IDNCT07220525
StatusRECRUITING
Start Date2025-12-15
Completion2027-06-01
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

Whereas the available evidence mostly supports chronic sleep disruption as a risk factor for incident AF, less is known about the near-term risk of a discrete atrial fibrillation (AF) episode following a night of disrupted or poor-quality sleep. This prospective, randomized, case-crossover study aims to examine the acute effects of sleep disruption on clinically relevant cardiac ectopy pertinent to AF.

Frequently Asked Questions

What is Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation?

Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation is a clinical trial registered under NCT07220525. Current status: RECRUITING.

What is the status of NCT07220525?

The current status of NCT07220525 (Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation) is: RECRUITING.

When did Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation start?

Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation started on 2025-12-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑